Drug & supplement interaction

Yellow Loosestrife + Ustekinumab

Ustekinumab brand name: Stelara.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Yellow Loosestrife and Ustekinumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Yellow Loosestrife and Ustekinumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ustekinumab and Yellow Loosestrife in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Yellow Loosestrife at all — not against Ustekinumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Yellow Loosestrife safety at a glance

Yellow Loosestrife overall Not established Human safety data are very limited, so use cautiously and talk to a healthcare provider first.
Pregnancy Avoid Not enough safety information exists, so it is best avoided during pregnancy.
Breastfeeding Avoid Safety while breastfeeding is unknown, so avoid it to be safe.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ustekinumab and Yellow Loosestrife? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Ustekinumab’s Own FDA Label Lists

This is not an interaction — none of it involves Yellow Loosestrife. These are the most notable effects listed in the ADVERSE REACTIONS section of Ustekinumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 2 of them are worth acting on rather than waiting out — marked below.

  • A higher chance of infection Worth acting on
  • An allergic reaction Worth acting on
  • Joint pain mentioned in 5.7% of FDA reports for Ustekinumab
  • Back pain
  • Fever
  • Tiredness mentioned in 6.7% of FDA reports for Ustekinumab
  • Itching
  • Stomach pain
  • Dizziness
  • Headache mentioned in 5.2% of FDA reports for Ustekinumab

Showing the 10 most notable of 13 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ustekinumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 100,563 voluntary FDA FAERS reports for Ustekinumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Yellow Loosestrife’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Yellow Loosestrife side to compare — that is a limit of the record, not a statement that Yellow Loosestrife has no side effects.

Overlapping uses

What Ustekinumab Is Prescribed For, and What Yellow Loosestrife Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Ustekinumab is a prescription medicine with approved uses on its FDA label. Yellow Loosestrife is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Ustekinumab is prescribed for: Ustekinumab injection treats four immune-related conditions. It is approved for moderate to severe plaque psoriasis and active psoriatic arthritis in adults and children 6 years of age and older. It also treats moderately to severely active Crohn's disease in adults and children 2 years of age and older. For moderately to severely active ulcerative colitis, ustekinumab injection is approved for adult patients only.

Read the rest of what Ustekinumab is prescribed for

A prescriber will determine which condition is being treated and choose the appropriate product, route, and dosing schedule.

Yellow Loosestrife has been studied for:

  • Diarrhea studied, not established Yellow Loosestrife has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Yellow Loosestrife for diarrhea

    Although there is interest in using oral yellow loosestrife for diarrhea, there is insufficient reliable information about the clinical effects of yellow loosestrife for this condition.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Ustekinumab on your own; if you are taking Yellow Loosestrife for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Ustekinumab

This page covers Yellow Loosestrife only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Ustekinumab page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).

By severity: 52 moderate · 1 minor.

From our pharmacist’s overview on the Ustekinumab page

“Nothing on this page should scare anyone off ustekinumab (Stelara), but the pattern is worth knowing. Stelara treats psoriasis, psoriatic arthritis, and Crohn's disease by quieting part of the immune system, and all 53 supplements here are flagged for the same reason.”

Reviewed by 2 · Jul 18, 2026

Open the Ustekinumab interaction page

How much people look this up

Where Yellow Loosestrife and Ustekinumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Yellow Loosestrife
Steady interest

#1,086 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Ustekinumab
Steady interest

#1,481 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Yellow Loosestrife is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Yellow Loosestrife reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 27, 2026. The Yellow Loosestrife and Ustekinumab records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Yellow Loosestrife

What is Yellow Loosestrife?

  • Diarrhea and digestive upset
  • Minor wounds and bleeding
  • Mouth and throat irritation
  • Mild gastrointestinal complaints

Yellow loosestrife (Lysimachia vulgaris) is a traditional European herb used mostly for diarrhea, minor bleeding, and mouth or throat irritation. There is very little modern scientific evidence to confirm it works, and its safety has not been well studied, so it should be used cautiously and avoided in pregnancy and breastfeeding.

Lysimachia vulgaris · Primulaceae · Aerial parts (leaves, stems, and flowers) · Tea (infusion), tincture, dried herb, occasionally topical preparations

An interaction check asks whether these two react with each other — it does not ask whether Yellow Loosestrife is a good idea for someone in your situation. Here is what our Yellow Loosestrife record says about it on its own.

Yellow Loosestrife: dosing

There is no established standard dose for yellow loosestrife. Modern science has not determined a safe or effective amount.If you choose to use a product, follow the directions on the label and do not exceed them.

From our Yellow Loosestrife monograph — the full record covers uses, side effects and every documented interaction.

Read the full Yellow Loosestrife monograph & all interactions
Medication

About Ustekinumab Injection

What Is Ustekinumab Injection Used For?

Brand name: Stelara

Ustekinumab injection treats four immune-related conditions. It is approved for moderate to severe plaque psoriasis and active psoriatic arthritis in adults and children 6 years of age and older. It also treats moderately to severely active Crohn's disease in adults and children 2 years of age and older.

For moderately to severely active ulcerative colitis, ustekinumab injection is approved for adult patients only. A prescriber will determine which condition is being treated and choose the appropriate product, route, and dosing schedule.

Most-Reported Side Effects for Ustekinumab

From FAERS, the FDA’s public side-effect reporting system (0 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Fatigue 6,866 reports
Psoriasis 6,590 reports
Crohn^s disease 5,912 reports
Arthralgia 5,840 reports
Rash 5,635 reports
See full Ustekinumab Injection drug information
Keep checking

Other Drugs & Yellow Loosestrife

Browse every other medication we’ve checked against Yellow Loosestrife — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Yellow Loosestrife References

The 2 sources that drive our Yellow Loosestrife monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Yellow Loosestrife is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Herbs at a Glance — NIH National Center for Complementary and Integrative Health Source
  2. Herbs and Supplements — MedlinePlus (U.S. National Library of Medicine) Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Yellow Loosestrife and Ustekinumab Together: Common Questions

Is it safe to take Yellow Loosestrife with Ustekinumab?
We do not list a known interaction between Yellow Loosestrife and Ustekinumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Are Yellow Loosestrife and Ustekinumab used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Yellow Loosestrife in each. That is a conversation for your prescriber, especially if Ustekinumab is being adjusted to a target.
Does Ustekinumab interact with any supplements?
Yes. Ustekinumab has documented interactions with 53 supplements in our database — Yellow Loosestrife is not one of them. The Ustekinumab interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Ustekinumab and Yellow Loosestrife?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.